Form SC 13G/A ARS Pharmaceuticals, Filed by: FMR LLC
Tweet
Share
E-mailGet inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
ATTACHMENTS / EXHIBITS
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ARS Pharmaceuticals (SPRY) Announces FDA AdCom Schedules Meeting over neffy for May 11, 2023
- Reed's (REED) Appoints Joann Tinnelly as Interim CFO
- ARS Pharmaceuticals Announces FDA Advisory Committee for neffy® for the Treatment of Allergic Reactions (Type 1), Including Anaphylaxis
Create E-mail Alert Related Categories
SEC FilingsRelated Entities
Fidelity Investments, 13GSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
